Robert Dally

Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38α MAP kinase inhibitors with excellent in vivo antiinflammatory properties

Mary M. Mader, Alfonso de Dios, Chuan Shih et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 117 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach

Roger A. Smith, J A Barbosa, Cheri L. Blum et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 85 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17

Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine binding

D. E. Johnson, Sarah L. Heald, Robert Dally et al. · Prostaglandins Leukotrienes and Essential Fatty Acids · 1993 · 74 citations

Medicine, Medicinal Chemistry, Pharmacology +10

A Selective Estrogen Receptor Modulator Designed for the Treatment of Uterine Leiomyoma with Unique Tissue Specificity for Uterus and Ovaries in Rats

Conrad W. Hummel, Andrew G. Geiser, Henry U. Bryant et al. · Journal of Medicinal Chemistry · 2005 · 51 citations · Full text

Medicine, Endocrinology, Pharmacology +17

p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas

Anikó M. Redman, Jeffrey S. Johnson, Robert Dally et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 44 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9